COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients

COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients

Abstract The role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent plasma in the treatment of Coronavirus Disease 2019 (COVID-19) in immunosuppressed individuals remains controversial. We describe the course of COVID-19 in patients who had received anti-CD20 therapy withi...

Full description

Bibliographic Details
Main Authors: Mary J. Kasten, Brian D. Lahr, Anusha Parisapogu, Zachary A. Yetmar, John C. O’Horo, Robert Orenstein, Pablo Moreno Franco, Raymund R. Razonable, Paschalis Vergidis, Aditya S. Shah, Mark J. Enzler, David J. Inwards, Philippe R. Bauer
Format: Article
Language:English
Published: Nature Portfolio 2023-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-48145-x

Internet

https://doi.org/10.1038/s41598-023-48145-x

Similar Items